IIT-AWAN-INITIUM-HN
Phase II
OPEN TO ACCRUAL
Immunotherapy and Nodal-Sparing Irradiation for T Cell Induction and Unmasking of Tumor Antigenicity in the Microenvironment for Head and Neck Cancer
NEOGENE-NT-175-201
Phase I
OPEN TO ACCRUAL
An Open-Label, Phase 1, Multicenter Study to Evaluate the Safety and Preliminary Anti-Tumor Activity of NT-175 in Human Leukocyte Antigen-A*02:01-Positive Adult Subjects with Unresectable, Advanced and or Metastatic Solid Tumors That Are Positive for the TP53 R175H Mutation
NRG-HN006
Phase II/III
OPEN TO ACCRUAL
Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer
NRG-HN010
Phase II
OPEN TO ACCRUAL *
A Controlled, Randomized Phase II Trial of Docetaxel Plus Trastuzumab Versus Ado-Trastuzumab Emtansine for Recurrent, Metastatic, or Treatment-Naïve, Unresectable HER2-Positive Salivary Gland Cancer